Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹666.3420₹23.6750
NAV date20 Nov 202620 Nov 2026
History13.9 years3.1 years
Expense ratio1.0%1.1%
Stars★★★★★★★★★★
Growth Score75.2094.50

Returns

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
1 month+11.40%+12.97%
3 months+3.74%+7.13%
6 months+8.55%+17.84%
YTD+16.94%+33.73%
1 year+15.26%+32.20%
3 years (CAGR)+17.96%+30.70%
5 years (CAGR)+15.40%—
10 years (CAGR)+16.61%—
Since launch+17.63%+31.83%

Risk

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Volatility14.1%15.8%
Downside volatility9.0%8.5%
Sharpe0.811.53
Sortino1.282.86
Calmar1.222.06
Return / risk1.271.95
Deepest fall−24.02%−14.91%
Days to recover445126
Below its high+0.00%+0.00%

Against benchmark

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Alpha−1.86%+7.54%
Beta0.890.97
R²89.5%85.0%
Up capture85.2%108.9%
Down capture88.7%71.0%
Tracking error4.8%6.1%
Information ratio−0.691.17
Treynor0.120.24

Consistency

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Best 1-year+90.70%+67.01%
Middle 1-year+13.13%+23.25%
Worst 1-year−15.12%+1.71%
1-year periods with a loss23.2%0.0%
Middle 3-year+19.82%+30.22%
Positive months63.9%72.2%
Best day+3.40%+3.18%
Worst day−3.21%−3.61%
Worst 5% day−1.38%−1.51%
Positive days53.7%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
5-year XIRR+18.24%—
5-year value₹9,54,076—
3-year XIRR+14.26%+27.71%
1-year XIRR+22.08%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth